I am pleased and excited to serve as Chair of the PVD Council for the next two years. Our Council is a vibrant, interdisciplinary council whose members are focused on improving the care of patients with vascular diseases through advancing science, education, advocacy, and improved healthcare delivery. To achieve our goals within the AHA we need to continue to grow our membership and foster their active involvement in all of our educational programs and scientific initiatives. This means we need you!
The PVD Council provides its scientific programming at two primary venues- Scientific Sessions and the Spring ATVB/PVD Council meeting. Please plan to attend AHA Sessions this November 16-20 in Dallas, Texas. To facilitate navigation at Sessions for our members we created a PVD Track several years ago, highlighting all of the vascular-related sessions (which this year will number 36!). A highlight at the meeting is our early career program, the Fellows-in-Training (FIT) Workshop, which provides a comprehensive overview of contemporary vascular disease management with outstanding lectures by leading experts. The FIT also includes sessions on career development, mentoring, and is a great networking opportunity.
The spring ATVB/PVD joint meeting has become the prime venue for vascular science-- with its broad offerings in basic, translational, and clinical science in vascular disease. Joint programming with ATVB Council and the Society for Vascular Surgery has created outstanding multidisciplinary sessions, making this meeting a wonderful opportunity for investigators at every level. The abstract and poster sessions are of highest quality and offer great interactions. Please mark you calendars early for next year’s meeting May 1-3, 2014 in Toronto.
Our Council also develops Scientific Statements and Guidelines related to vascular diseases. We invite your suggestions on topics of interest to the vascular community.
I look forward to working with all of you on the PVD Council over the coming two years, and to work within the AHA to advance our common cause of improving vascular health.
Michael Conte, MD, FAHA
Chair, Peripheral Vascular Disease Council